BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cano A, Sánchez-López E, Ettcheto M, López-Machado A, Espina M, Souto EB, Galindo R, Camins A, García ML, Turowski P. Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases. Nanomedicine (Lond) 2020;15:1239-61. [PMID: 32370600 DOI: 10.2217/nnm-2019-0443] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Cano A, Ettcheto M, Espina M, López-Machado A, Cajal Y, Rabanal F, Sánchez-López E, Camins A, García ML, Souto EB. State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections. J Nanobiotechnology 2020;18:156. [PMID: 33129333 DOI: 10.1186/s12951-020-00714-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Hanieh PN, Bonaccorso A, Zingale E, Cimarelli S, Souto EB, Rinaldi F, Marianecci C, Pignatello R, Carafa M. Almond oil O/W nanoemulsions: Potential application for ocular delivery. Journal of Drug Delivery Science and Technology 2022;72:103424. [DOI: 10.1016/j.jddst.2022.103424] [Reference Citation Analysis]
3 Gudz KY, Antipina LY, Permyakova ES, Kovalskii AM, Konopatsky AS, Filippovich SY, Dyatlov IA, Slukin PV, Ignatov SG, Shtansky DV. Ag-Doped and Antibiotic-Loaded Hexagonal Boron Nitride Nanoparticles as Promising Carriers to Fight Different Pathogens. ACS Appl Mater Interfaces 2021;13:23452-68. [PMID: 34000197 DOI: 10.1021/acsami.1c03775] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Zielińska A, Carreiró F, Oliveira AM, Neves A, Pires B, Venkatesh DN, Durazzo A, Lucarini M, Eder P, Silva AM, Santini A, Souto EB. Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology. Molecules 2020;25:E3731. [PMID: 32824172 DOI: 10.3390/molecules25163731] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 27.5] [Reference Citation Analysis]
5 Annu, Sartaj A, Qamar Z, Md S, Alhakamy NA, Baboota S, Ali J. An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor. Front Bioeng Biotechnol 2022;10:788128. [DOI: 10.3389/fbioe.2022.788128] [Reference Citation Analysis]
6 Cunha A, Gaubert A, Latxague L, Dehay B. PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases. Pharmaceutics 2021;13:1042. [PMID: 34371733 DOI: 10.3390/pharmaceutics13071042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kim GG, Jang HM, Park SB, So JS, Kim SW. Synthesis of Zr-89-Labeled Folic Acid-Conjugated Silica (SiO2) Microwire as a Tumor Diagnostics Carrier for Positron Emission Tomography. Materials (Basel) 2021;14:3226. [PMID: 34207994 DOI: 10.3390/ma14123226] [Reference Citation Analysis]
8 Kumar R, Aadil KR, Mondal K, Mishra YK, Oupicky D, Ramakrishna S, Kaushik A. Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology. Crit Rev Biotechnol 2021;:1-33. [PMID: 34823433 DOI: 10.1080/07388551.2021.1993126] [Reference Citation Analysis]
9 Cano A, Turowski P, Ettcheto M, Duskey JT, Tosi G, Sánchez-López E, García ML, Camins A, Souto EB, Ruiz A, Marquié M, Boada M. Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer's disease: from current to future challenges. J Nanobiotechnology 2021;19:122. [PMID: 33926475 DOI: 10.1186/s12951-021-00864-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Tamil Selvan S, Ravichandar R, Kanta Ghosh K, Mohan A, Mahalakshmi P, Gulyás B, Padmanabhan P. Coordination chemistry of ligands: Insights into the design of amyloid beta/tau-PET imaging probes and nanoparticles-based therapies for Alzheimer’s disease. Coordination Chemistry Reviews 2021;430:213659. [DOI: 10.1016/j.ccr.2020.213659] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Waris A, Ali A, Khan AU, Asim M, Zamel D, Fatima K, Raziq A, Khan MA, Akbar N, Baset A, Abourehab MAS. Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders. Nanomaterials 2022;12:2140. [DOI: 10.3390/nano12132140] [Reference Citation Analysis]
12 Revdekar A, Shende P. Block copolymers in Alzheimer's disease therapy: A perceptive to revolutionize biomaterials. J Control Release 2021;340:271-81. [PMID: 34763003 DOI: 10.1016/j.jconrel.2021.11.007] [Reference Citation Analysis]
13 Zhou Z, Sun T, Jiang C. Recent advances on drug delivery nanocarriers for cerebral disorders. Biomed Mater 2021;16:024104. [PMID: 33455956 DOI: 10.1088/1748-605X/abdc97] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Bonilla L, Esteruelas G, Ettcheto M, Espina M, García ML, Camins A, Souto EB, Cano A, Sánchez-López E. Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges. Epilepsia Open 2021. [PMID: 34862851 DOI: 10.1002/epi4.12567] [Reference Citation Analysis]
15 Cano A, Ettcheto M, Espina M, Auladell C, Folch J, Kühne BA, Barenys M, Sánchez-López E, Souto EB, García ML, Turowski P, Camins A. Epigallocatechin-3-gallate PEGylated poly(lactic-co-glycolic) acid nanoparticles mitigate striatal pathology and motor deficits in 3-nitropropionic acid intoxicated mice. Nanomedicine (Lond) 2021;16:19-35. [PMID: 33410329 DOI: 10.2217/nnm-2020-0239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yang J, Zhou M, Li W, Lin F, Shan G. Preparation and Evaluation of Sustained Release Platelet-Rich Plasma-Loaded Gelatin Microspheres Using an Emulsion Method. ACS Omega 2020;5:27113-8. [PMID: 33134671 DOI: 10.1021/acsomega.0c02543] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Tagde P, Najda A, Nagpal K, Kulkarni GT, Shah M, Ullah O, Balant S, Rahman MH. Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management. IJMS 2022;23:2856. [DOI: 10.3390/ijms23052856] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Okey‐onyesolu CF, Hassanisaadi M, Bilal M, Barani M, Rahdar A, Iqbal J, Kyzas GZ. Nanomaterials as Nanofertilizers and Nanopesticides: An Overview. ChemistrySelect 2021;6:8645-63. [DOI: 10.1002/slct.202102379] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
19 El-Ghoul Y, Alminderej FM, Alsubaie FM, Alrasheed R, Almousa NH. Recent Advances in Functional Polymer Materials for Energy, Water, and Biomedical Applications: A Review. Polymers (Basel) 2021;13:4327. [PMID: 34960878 DOI: 10.3390/polym13244327] [Reference Citation Analysis]
20 Cano A, Fonseca E, Ettcheto M, Sánchez-López E, de Rojas I, Alonso-Lana S, Morató X, Souto EB, Toledo M, Boada M, Marquié M, Ruíz A. Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways. Pharmaceuticals (Basel) 2021;14:1057. [PMID: 34681281 DOI: 10.3390/ph14101057] [Reference Citation Analysis]
21 Shukla R, Singh A, Handa M, Flora SJS, Kesharwani P. Nanotechnological approaches for targeting amyloid-β aggregation with potential for neurodegenerative disease therapy and diagnosis. Drug Discov Today 2021;26:1972-9. [PMID: 33892144 DOI: 10.1016/j.drudis.2021.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]